What is the proper usage and dosage of Etizolam (thienodiazepine) for treating anxiety and insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etizolam for Anxiety and Insomnia

Etizolam is not FDA-approved in the United States for treating anxiety or insomnia, and its use should be avoided due to significant risks of dependence, cognitive impairment, and abuse potential.

Overview and Classification

  • Etizolam is a thienodiazepine with pharmacological properties similar to benzodiazepines, acting on GABA-A receptors 1
  • While approved for medical use in some countries like Japan, Italy, and South Korea, it is considered a controlled substance in many countries due to abuse potential 1
  • Etizolam has been increasingly misused as a recreational drug and is classified as a new psychoactive substance (NPS) by the World Health Organization since 2015 2

Recommended Alternatives for Anxiety and Insomnia

FDA-Approved Medications for Insomnia

For insomnia, the following FDA-approved medications are recommended instead:

Non-benzodiazepines:

  • Eszopiclone: 2-3 mg at bedtime (1 mg for elderly or those with hepatic impairment) 3
  • Zolpidem: 10 mg at bedtime (5 mg for elderly) 3
  • Zaleplon: 10 mg at bedtime (5 mg for elderly or hepatic impairment) 3

Benzodiazepines:

  • Estazolam: 1-2 mg at bedtime (0.5 mg for elderly) 3, 4
  • Temazepam: 15-30 mg at bedtime (7.5 mg for elderly) 3
  • Triazolam: 0.25 mg at bedtime (0.125 mg for elderly) 3

Other options:

  • Ramelteon (melatonin receptor agonist): 8 mg at bedtime 3
  • Doxepin (low-dose): 3-6 mg at bedtime 3

FDA-Approved Medications for Anxiety

For anxiety, the following medications are recommended:

Benzodiazepines:

  • Lorazepam: 0.5-1 mg 2-3 times daily 3
  • For elderly patients: start with lower doses (0.25-0.5 mg) 3

Antidepressants:

  • SSRIs (for long-term anxiety management):

    • Paroxetine: 10-40 mg daily 3
    • Sertraline: 25-200 mg daily 3
    • Citalopram: 10-40 mg daily 3
  • Other antidepressants:

    • Mirtazapine: 7.5-30 mg at bedtime (beneficial for both anxiety and insomnia) 3
    • Trazodone: 25-200 mg daily (for anxiety with insomnia) 3

Risks of Etizolam Use

  • High potential for dependence and withdrawal symptoms, even when prescribed for medical reasons 5
  • Cognitive impairment at high doses, affecting working memory, visuospatial memory, and executive function 5
  • While low therapeutic doses (0.25-1.0 mg) may have minimal effects on psychomotor performance, abuse at higher doses can lead to significant impairment 2
  • Risk of tolerance development requiring dose escalation 5
  • Metabolizes into two major metabolites (α-hydroxyetizolam and 8-hydroxyetizolam) that contribute to its effects 1

Dosing Considerations for Benzodiazepines and Similar Agents

  • Administration on an empty stomach maximizes effectiveness 3
  • Not recommended during pregnancy or nursing 3
  • Use with caution in patients with:
    • Respiratory conditions (asthma, COPD, sleep apnea) 3
    • Hepatic impairment 3
    • Elderly patients (require dose reduction) 3
  • Avoid combining with other CNS depressants or alcohol 3
  • Rapid dose reduction or abrupt discontinuation can produce withdrawal symptoms 3

Monitoring and Safety

  • Monitor for signs of dependence and tolerance 5
  • Assess cognitive function periodically in patients on long-term therapy 5
  • Implement a tapering schedule when discontinuing to minimize withdrawal symptoms 3
  • Be aware that benzodiazepines can cause paradoxical agitation in approximately 10% of patients 3

Conclusion

For treating anxiety and insomnia, FDA-approved medications with established safety profiles should be used instead of etizolam. The evidence supports using traditional benzodiazepines, non-benzodiazepine hypnotics, or certain antidepressants based on the specific presentation and patient characteristics.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.